ACADIA Pharmaceuticals Inc (ACAD) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]
ACADIA Pharmaceuticals Inc. (ACAD)
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.acadia-pharm.com/phoenix.zhtml?c=125180&p=irol-irhome
Company Research
Source: Yahoo! Finance
DAYBUE Sales (Q4 2024): $96.7 million, up 11% year over year and 6% sequentially. DAYBUE Sales (Full Year 2024): $348.4 million, up 97% from 2023. NUPLAZID Sales (Q4 2024): $162.9 million, up 13% year over year. NUPLAZID Sales (Full Year 2024): $609.4 million, up 11% from the prior year. R&D Expenses (Full Year 2024): $303.2 million, decreased from $351.6 million in 2023. SG&A Expenses (Full Year 2024): $488.4 million, increased from $406.6 million in 2023. Cash Balance (End of 2024): $756 million, up from $438.9 million at the end of 2023. 2025 Revenue Guidance: $1.03 billion to $1.095 billion. DAYBUE 2025 Sales Guidance: $380 million to $405 million in the US. NUPLAZID 2025 Sales Guidance: $650 million to $690 million. Warning! GuruFocus has detected 2 Warning Sign with ACAD. Release Date: February 26, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points ACADIA Pharmaceuticals Inc ( NASD
Show less
Read more
Impact Snapshot
Event Time:
ACAD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACAD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACAD alerts
High impacting ACADIA Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
ACAD
News
- Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 [Yahoo! Finance]Yahoo! Finance
- Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026Business Wire
- From biotech to defense, here are 10 top stock picks for 2026 from UBS [Yahoo! Finance]Yahoo! Finance
- From biotech to defense, here are 10 top stock picks for 2026 from UBS [Business Insider]Business Insider
- ACADIA Pharmaceuticals (NASDAQ:ACAD) was given a new $37.00 price target on by analysts at Piper Sandler.MarketBeat
ACAD
Earnings
- 11/5/25 - Beat
ACAD
Sec Filings
- 11/19/25 - Form 4
- 11/19/25 - Form 4
- 11/14/25 - Form SCHEDULE
- ACAD's page on the SEC website